TIETOJA TÄSTÄ PODCASTISTA 🔗
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences.
Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business.
You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter strategic decisions - at www.corrdyn.com
Juontajat:
Päivitä taajuus:
biweekly
Keskimääräinen äänen pituus:
45 minutes
Vierashaastattelut
On sponsoreita
Englanti
Yhdysvallat
80 jaksoa
vuodesta 25. syyskuuta 2023
episodic
VIIMEISIN JAKSO 🔗
AI can design a molecule in seconds, however someone still has to build it and test it before it means anything.
You're pouring resources into AI-driven molecule design, but nobody on your team has answered the harder question: can you actually make what the model just designed?
Patrick Finn is…
HAE EDELLISIÄ EPISODEJA
Hae kanavan Data in Biotech vanhoja jaksoja.
EDELLISET JAKSOT 🔗
Flow cytometry can find a cell population in seconds, but naming it consistently across labs is a problem still unsolved.
If you've ever tried to compare cytometry data across studies, CROs, or even two scientists in the same lab, you know the frustration: everyone gates their own way, and the sa…
Ask a general AI model how many approved drugs hit a target, and it might tell you three when the real answer is six, sounding just as confident either way.
If your team is grounding drug discovery decisions in AI output with no way to trace where the answer came from, you're one regulator's ques…
Most drug discovery genomic data comes from a thin slice of the world, and that bias follows every decision downstream.
Your team can run a Mendelian randomization study on 35,000 patients and still walk away with a single signal that doesn't even apply to the population you care about. If your p…
Why treating the cell, not the protein, could turn chronic disease treatment into something closer to a cure.
You've built single-cell pipelines that spit out clusters, p-values and target lists, but nothing that survives contact with the clinic. What if the clustering method itself is quietly le…
Everyone in biotech agrees AI needs more data. Almost no one is willing to pay for it.
If you're trying to build or buy a biotech AI model, you've hit the same wall: predictive performance depends on data your budget doesn't cover, and nobody in the field seems willing to close that gap.
John A…
In this episode of Data in Biotech, host Ross Katz sits down with Woody Sherman, Founder and Chief Innovation Officer at PsiThera, for a conversation on why AI can transform drug discovery's paperwork and code while barely touching the hardest part of the problem: the molecules themselves. Woody's …
In this episode of Data in Biotech, host Ross Katz sits down with Paul Finn, Chief Scientific Officer at Oxford Drug Design, for a conversation on what it actually takes to find a drug molecule that works not just on paper but also in the lab, in the cell, and, ultimately, in the clinic. Paul bring…
In this episode of Data in Biotech, host Ross Katz sits down with Arvind Rao, Professor of Computational Medicine and Bioinformatics at the University of Michigan, for a discussion on the gap between what biomedical AI can do and what it can reliably be trusted to do in clinical practice. Arvind's …
In this episode of Data in Biotech, host Ross Katz sits down with Sadegh Salehi, Director of Research and Principal Scientist at Overjet, to explore what rigorous model evaluation actually looks like when the stakes are clinical.
Overjet builds FDA-cleared vision models that detect and quantify …
Vastuuvapautusilmoitus: Tälle sivulle upotettu podcast ja kuvitus ovat peräisin CorrDyn:ltä, joka on sen omistajan omaisuutta, eikä se ole sidoksissa Listen Notes, Inc:n tukemaan.
PODCAST-HAKUKONEET
Voit käyttää verkkosivustoamme etsiäksesi3,823,508-podcasteja ja195,665,994-jaksoja ihmisten, paikkojen tai aiheiden mukaan.
Tietoon sijoittaminen tuottaa parhaiten, joten kuuntelen podcasteja.
‐ Benjamin "Llamacorn" Franklin
HAE EDELLISIÄ EPISODEJA
Hae kanavan Data in Biotech vanhoja jaksoja.
LUNASTA TÄMÄ PODCAST
Why to claim podcasts?
If you are a podcaster, the best way to manage your podcasts on Listen Notes is by claiming your Listen Notes
podcast pages.
It is a great, free way to engage the podcast community and increase the visibility of your podcasts.
After claiming your Listen Notes podcast pages, you will be able to:
✓
Manually refresh the RSS feed to sync up
✓
Get a verified badge (
✓
) alongside with your podcast name on Listen Notes
✓
Post luokitellut ilmoitukset for sponsorship,
guests, co-hosts,
cross-promotion...
✓
Respond to listener comments on Listen Notes
✓
Use speech-to-text techniques to transcribe your show and
edit transcripts
✓
Improve the presence of your podcasts, e.g., self-service
podcast-tekijän haastattelu...
✓
If you share your Listen Notes page and at-mention @ListenNotes
on X (formerly Twitter),
virallinen X-tilimme (entinen Twitter) will retweet to promote
your show to our followers.
Coming soon:
◯ Self-service promotion on Listen Notes
◯ Track your podcast stats on Listen
Notes, e.g., listens, page
views...
◯ Manage episodes
MUOKKAA
Kiitos, kun autoit pitämään podcast-tietokantaa ajan tasalla.
